Living-Donor Lung Transplantation for Post–COVID-19 Respiratory Failure

This report describes a case of coronavirus disease 2019 (COVID-19)–associated respiratory failure requiring urgent living-donor lobar lung transplantation (LDLLTx). Severe hypoxia requiring extracorporeal membrane oxygenation (ECMO) developed in a 57-year-old woman with positive viral status. Her r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohsumi, Akihiro, Takamatsu, Jumpei, Yuasa, Itsuki, Tanaka, Satona, Yutaka, Yojiro, Hamaji, Masatsugu, Nakajima, Daisuke, Yamazaki, Kazuhiro, Nagao, Miki, Date, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by The Society of Thoracic Surgeons 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570407/
https://www.ncbi.nlm.nih.gov/pubmed/34748735
http://dx.doi.org/10.1016/j.athoracsur.2021.10.003
Descripción
Sumario:This report describes a case of coronavirus disease 2019 (COVID-19)–associated respiratory failure requiring urgent living-donor lobar lung transplantation (LDLLTx). Severe hypoxia requiring extracorporeal membrane oxygenation (ECMO) developed in a 57-year-old woman with positive viral status. Her respiratory function deteriorated, with almost totally collapsed lungs. All of her other organs functioned well. After 104 days of ECMO support, she underwent urgent LDLLTx using cardiopulmonary bypass. The grafts worked well, and she was weaned from cardiopulmonary bypass after reperfusion. LDLLTx is an option for selected patients with post–COVID-19 end-stage respiratory failure.

Ejemplares similares